Related Experiment Video
Updated: Jul 4, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with
Rubén Queiro1,2,3, Ignacio Braña1, Estefanía Pardo1
1Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.
Insights
The HLA-Cw6 allele in psoriasis patients did not directly improve cardiometabolic health. Its apparent benefits on cardiovascular risk factors were explained by other patient characteristics, not the allele itself.
Area of Science:
- Immunodermatology
- Cardiology
- Genetics
Background:
- Cardiovascular comorbidity is prevalent in psoriasis and psoriatic arthritis (PsA).
- A potential link between HLA-Cw6 allele and improved cardiometabolic profile in these patients has been suggested.
- This study aimed to validate this association in a distinct patient cohort.
Purpose of the Study:
- To investigate the association between the HLA-Cw6 allele and cardiometabolic risk factors in patients with psoriasis and PsA.
- To determine if the HLA-Cw6 allele influences cardiometabolic health independently of other clinical factors.
- To explore the role of IFIH1/MDA5 gene variants in relation to PsA and cardiometabolic risk.
Main Methods:
- A cross-sectional observational study of 572 psoriasis patients (30% with PsA).
- Collection of detailed clinical variables and cardiometabolic risk factors.
- Genotyping for HLA-Cw6 allele and IFIH1/MDA5 gene variants (rs1990760).
- Analysis using linear and logistic regression models to assess associations.
Main Results:
- HLA-Cw6 was confirmed to be associated with type I psoriasis.
- HLA-Cw6 was found to be protective against PsA (OR: 0.65).
- Initially, HLA-Cw6 carriers showed lower waist perimeter, BMI, and reduced risk of hypertension and diabetes, but these associations disappeared after adjusting for other factors.
- No IFIH1/MDA5 gene variant was linked to cardiometabolic risk factors.
Conclusions:
- The apparent protective effect of HLA-Cw6 on the cardiometabolic profile in psoriatic patients is likely mediated by other factors such as age, sex, disease duration, or presence of arthritis.
- The HLA-Cw6 biomarker itself may not be an independent predictor of cardiometabolic risk in this population.
Background:
Cardiovascular comorbidity is a common companion of psoriasis and psoriatic arthritis (PsA). Recently, a significant link has been found between the HLA-Cw6 allele and a better cardiometabolic profile in these patients. We aimed to check this finding in our setting.
Methods:
A cross-sectional observational study (n: 572 psoriasis patients, 30% with PsA) was conducted. Different study variables were collected in detail, as well as classic cardiometabolic risk factors. The distribution of the HLA-Cw6 allele and the IFIH1/MDA5 gene variants previously linked to disease risk were determined in the study cohort and stratified according to the cardiometabolic comorbidity. Linear and logistic regression models were constructed to analyze these associations.
Results:
The study cohort included 309 men and 263 women, with a mean age of 46.7 years (SD 14.5) and a mean disease duration of 19.4 years (SD 14.8). We confirmed the known association between HLA-Cw6 and type I psoriasis (familial, severe, and early onset). Psoriasis severity (OR: 2.14), female sex (OR: 1.63), and the IFIH1/MDA5 rs1990760 TT genotype (OR: 1.62) were significantly related to PsA, while HLA-Cw6 was protective (OR: 0.65). HLA-Cw6 carriers showed a lower waist perimeter, lower BMI, and lower risk of both hypertension (OR: 0.52, p < 0.001) and diabetes (OR: 0.36, p < 0.001), but these findings were no longer apparent upon adjusting the regression models. No IFIH1/MDA5 gene variant was associated with any cardiometabolic risk factor.
Conclusions:
The influence of HLA-Cw6 on the cardiometabolic risk profile of psoriatic patients seems to be explained by other factors (age, sex, duration of the disease or arthritis) and not by this biomarker itself.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...